Request Deal Involvement
Charterhouse Capital-backed SERB and Stark International Lux completed the acquisition of Boston Scientific's BTG Specialty Pharmaceuticals business for $800m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Shearman & Sterling
financial advisors
Wells Fargo Securities
financial advisors
Eight Advisory
pr advisors
Greenbrook
financial advisors
Rothschild & Co
or
Principals
bidder
CHARTERHOUSE CAPITAL PARTNERS
target
BOSTON SCIENTIFIC CORPORATION (BTG SPECIALTY PHARMACEUTICALS BUSINESS)
bidder
STARK INTERNATIONAL LUX
vendor
BOSTON SCIENTIFIC CORPORATION
bidder
SERB
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite